Literature DB >> 21865887

Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease.

Cyntia Tremblay1, Isabelle St-Amour, Julie Schneider, David A Bennett, Frédéric Calon.   

Abstract

Transactive response DNA binding protein 43 (TDP-43) plays a central role in the neuropathology of frontotemporal lobar degeneration and amyotrophic lateral sclerosis, but the relationship between TDP-43 abnormalities and Alzheimer disease (AD) remains unclear. To determine whether TDP-43 can serve as a neuropathologic marker of AD, we performed biochemical characterization and quantification of TDP-43 in homogenates from parietal neocortex of subjects with aclinical diagnosis of no cognitive impairment (NCI, n = 12), mild cognitive impairment (MCI, n = 12), or AD (n = 12). Immunoblots revealed increased detergent-insoluble TDP-43 in the cortex of 0, 3, and 6 of the 12 individuals with NCI, MCI, or AD, respectively. Detergent-insoluble TDP-43 was positively correlated with the accumulation of soluble Aβ42, amyloid plaques, and paired helical filamenttau. In contrast, phospho-TDP-43 was decreased in the cytosolic fraction and detergent-soluble membrane/nuclear fraction from AD patients and correlated with antemortem cognitive function.Immunofluorescence analysis confirmed that the frequencies of individuals with TDP-43 or phospho-TDP-43 cytoplasmic inclusions were higher in AD than in NCI, with MCI at an intermediate level. These data indicate that abnormalities of TDP-43 occur in an important subset of MCI and AD patients and that they correlate with the clinical and neuropathologic features of AD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21865887      PMCID: PMC3197017          DOI: 10.1097/NEN.0b013e31822c62cf

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  66 in total

Review 1.  The role of apoptotic pathways in Alzheimer's disease neurodegeneration and cell death.

Authors:  Andrea C LeBlanc
Journal:  Curr Alzheimer Res       Date:  2005-10       Impact factor: 3.498

2.  Epitope mapping of 2E2-D3, a monoclonal antibody directed against human TDP-43.

Authors:  Hai-Xin Zhang; Kunikazu Tanji; Fumiaki Mori; Koichi Wakabayashi
Journal:  Neurosci Lett       Date:  2008-02-02       Impact factor: 3.046

3.  Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease.

Authors:  T T Rohn; E Head; J H Su; A J Anderson; B A Bahr; C W Cotman; D H Cribbs
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

Review 4.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration.

Authors:  Clotilde Lagier-Tourenne; Magdalini Polymenidou; Don W Cleveland
Journal:  Hum Mol Genet       Date:  2010-04-15       Impact factor: 6.150

5.  Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology.

Authors:  Robert A Rissman; Wayne W Poon; Mathew Blurton-Jones; Salvatore Oddo; Reidun Torp; Michael P Vitek; Frank M LaFerla; Troy T Rohn; Carl W Cotman
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

6.  Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.

Authors:  Ian R A Mackenzie; Eileen H Bigio; Paul G Ince; Felix Geser; Manuela Neumann; Nigel J Cairns; Linda K Kwong; Mark S Forman; John Ravits; Heather Stewart; Andrew Eisen; Leo McClusky; Hans A Kretzschmar; Camelia M Monoranu; J Robin Highley; Janine Kirby; Teepu Siddique; Pamela J Shaw; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

7.  TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.

Authors:  Catalina Amador-Ortiz; Wen-Lang Lin; Zeshan Ahmed; David Personett; Peter Davies; Ranjan Duara; Neill R Graff-Radford; Michael L Hutton; Dennis W Dickson
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

8.  Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Masato Hasegawa; Tetsuaki Arai; Takashi Nonaka; Fuyuki Kametani; Mari Yoshida; Yoshio Hashizume; Thomas G Beach; Emanuele Buratti; Francisco Baralle; Mitsuya Morita; Imaharu Nakano; Tatsuro Oda; Kuniaki Tsuchiya; Haruhiko Akiyama
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

9.  Clinical and pathological continuum of multisystem TDP-43 proteinopathies.

Authors:  Felix Geser; Maria Martinez-Lage; John Robinson; Kunihiro Uryu; Manuela Neumann; Nicholas J Brandmeir; Sharon X Xie; Linda K Kwong; Lauren Elman; Leo McCluskey; Chris M Clark; Joe Malunda; Bruce L Miller; Earl A Zimmerman; Jiang Qian; Vivianna Van Deerlin; Murray Grossman; Virginia M-Y Lee; John Q Trojanowski
Journal:  Arch Neurol       Date:  2009-02

Review 10.  Current hypotheses for the underlying biology of amyotrophic lateral sclerosis.

Authors:  Jeffrey D Rothstein
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

View more
  35 in total

Review 1.  Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: Current Evidence and Future Perspectives.

Authors:  Donovan A McGrowder; Fabian Miller; Kurt Vaz; Chukwuemeka Nwokocha; Cameil Wilson-Clarke; Melisa Anderson-Cross; Jabari Brown; Lennox Anderson-Jackson; Lowen Williams; Lyndon Latore; Rory Thompson; Ruby Alexander-Lindo
Journal:  Brain Sci       Date:  2021-02-10

2.  Overview and findings from the religious orders study.

Authors:  David A Bennett; Julie A Schneider; Zoe Arvanitakis; Robert S Wilson
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

3.  TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.

Authors:  Mauro Montalbano; Salome McAllen; Filippa Lo Cascio; Urmi Sengupta; Stephanie Garcia; Nemil Bhatt; Anna Ellsworth; Eric A Heidelman; Omar D Johnson; Samantha Doskocil; Rakez Kayed
Journal:  Neurobiol Dis       Date:  2020-10-14       Impact factor: 5.996

4.  Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi.

Authors:  Vanessa D Smith; Adam D Bachstetter; Eseosa Ighodaro; Kelly Roberts; Erin L Abner; David W Fardo; Peter T Nelson
Journal:  Brain Pathol       Date:  2017-03-24       Impact factor: 6.508

Review 5.  Autophagy: A Lysosome-Dependent Process with Implications in Cellular Redox Homeostasis and Human Disease.

Authors:  Stefan W Ryter; Divya Bhatia; Mary E Choi
Journal:  Antioxid Redox Signal       Date:  2018-03-28       Impact factor: 8.401

6.  Much of late life cognitive decline is not due to common neurodegenerative pathologies.

Authors:  Patricia A Boyle; Robert S Wilson; Lei Yu; Alasdair M Barr; William G Honer; Julie A Schneider; David A Bennett
Journal:  Ann Neurol       Date:  2013-07-10       Impact factor: 10.422

7.  TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.

Authors:  Bryan D James; Robert S Wilson; Patricia A Boyle; John Q Trojanowski; David A Bennett; Julie A Schneider
Journal:  Brain       Date:  2016-11-01       Impact factor: 13.501

8.  Disentangling the effects of age and APOE on neuropathology and late life cognitive decline.

Authors:  Lei Yu; Patricia A Boyle; Sue Leurgans; Julie A Schneider; David A Bennett
Journal:  Neurobiol Aging       Date:  2013-10-09       Impact factor: 4.673

9.  Brain mural cell loss in the parietal cortex in Alzheimer's disease correlates with cognitive decline and TDP-43 pathology.

Authors:  P Bourassa; C Tremblay; J A Schneider; D A Bennett; F Calon
Journal:  Neuropathol Appl Neurobiol       Date:  2020-02-11       Impact factor: 8.090

10.  Neurodegenerative diseases: quantitative predictions of protein-RNA interactions.

Authors:  Davide Cirillo; Federico Agostini; Petr Klus; Domenica Marchese; Silvia Rodriguez; Benedetta Bolognesi; Gian Gaetano Tartaglia
Journal:  RNA       Date:  2012-12-21       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.